Cargando…

Workshop report on the 2(nd) Joint ENCCA/EuroSARC European bone sarcoma network meeting: integration of clinical trials with tumour biology

This is the report of the 2(nd) Joint ENCCA/EuroSARC European Bone Sarcoma Network Meeting held in Leiden, The Netherlands, on 26-27 September 2013, bringing together preclinical and clinical investigators on bone sarcoma. The purpose of this workshop was to present the achievements of biological re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anninga, Jakob K, Cleton-Jansen, Anne-Marie, Hassan, Bass, Amary, M Fernanda, Baumhoer, Daniel, Blay, Jean-Yves, Brugieres, Laurence, Ferrari, Stefano, Jürgens, Heribert, Kempf-Bielack, Beate, Kovar, Heinrich, Myklebost, Ola, Nathrath, Michaela, Picci, Piero, Riegman, Peter, Schilham, Marco W, Soliman, Ranin, Stark, Dan P, Strauss, Sandra, Sydes, Matthew, Tarpey, Patrick, Thomas, David, Whelan, Jeremy, Wilhelm, Miriam, Zamzam, Manal, Gelderblom, Hans, Bielack, Stefan S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014081/ http://dx.doi.org/10.1186/2045-3329-4-4

Ejemplares similares

The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24–25, 2015. Workshop Report
por: Kager, Leo, et al.
Publicado: (2016)

Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
por: Barnes, David J., et al.
Publicado: (2022)

DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma
por: Barenboim, Maxim, et al.
Publicado: (2021)

Report from the 4th European Bone Sarcoma Networking meeting: focus on osteosarcoma
por: Strauss, Sandra J., et al.
Publicado: (2018)

NTRK fusions in osteosarcoma are rare and non‐functional events
por: Ameline, Baptiste, et al.
Publicado: (2020)

CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients
por: Baumhoer, Daniel, et al.
Publicado: (2011)

The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies
por: Kovac, Michal, et al.
Publicado: (2021)

Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group
por: Mettmann, Vanessa L., et al.
Publicado: (2023)

Comment on: ‘Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?’
por: Bielack, S S
Publicado: (2012)

Systemic treatment for primary malignant sarcomas arising in craniofacial bones
por: Bielack, Stefan S.
Publicado: (2022)

The usefulness of SARC-F
por: Piotrowicz, Karolina, et al.
Publicado: (2021)

The IGF signalling pathway in Wilms tumours - A report from the ENCCA Renal Tumours Biology-driven drug development workshop
por: Maschietto, Mariana, et al.
Publicado: (2014)

A special jubilee: 100 fake osteosarcoma articles
por: Bielack, S.S., et al.
Publicado: (2021)

Comparison of Diagnostic Performance of SARC-F and Its Two Modified Versions (SARC-CalF and SARC-F+EBM) in Community-Dwelling Older Adults from Poland
por: Krzymińska-Siemaszko, Roma, et al.
Publicado: (2020)

Comparing SARC-CalF With SARC-F for Screening Sarcopenia in Adults With Type 2 Diabetes Mellitus
por: Xu, Zeru, et al.
Publicado: (2022)

Diagnostic performance of calf circumference, SARC-F, and SARC-CalF for possible sarcopenia screening in Indonesia
por: Kandinata, Stefanus G., et al.
Publicado: (2023)

Diagnostic performance of SARC-F and SARC-CalF in screening for sarcopenia in older adults in Northern Brazil
por: Barreto de Lima, Alex, et al.
Publicado: (2023)

Sarcopenia for predicting mortality among elderly nursing home residents: SARC-F versus SARC-CalF
por: Yang, Ming, et al.
Publicado: (2019)

Pan-European Sarcoma Trials: Moving Forward in a Climate of Increasing Economic and Regulatory Pressure
por: Carrle, Dorothe, et al.
Publicado: (2007)

Review of mifamurtide in the treatment of patients with osteosarcoma
por: Kager, Leo, et al.
Publicado: (2010)

The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
por: Saloustros, Emmanouil, et al.
Publicado: (2017)

Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma
por: Lancia, Carlo, et al.
Publicado: (2019)

Identification of Probable sarcopenia based on SARC-F and SARC-CalF in older adults from a low-resource setting
por: Vidal-Cuellar, Claudia L., et al.
Publicado: (2022)

Bone sarcoma: success through interdisciplinary collaboration
por: Hecker-Nolting, Stefanie, et al.
Publicado: (2021)

SARC-F and SARC-CalF Scores as Mortality Risk Factors in Older Men with Cancer: A Longitudinal Study from Peru
por: Ururi-Cupi, K., et al.
Publicado: (2022)

Evaluation of SARC-F and SARC-CalF for sarcopenia screening in patients with chronic musculoskeletal pain: A prospective cross-sectional study
por: Tsuji, Hironori, et al.
Publicado: (2022)

A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup
por: Lancia, Carlo, et al.
Publicado: (2019)

Comparison of SARC-F Score among Gastrointestinal Diseases
por: Ushiro, Kosuke, et al.
Publicado: (2021)

Accurate SARC-F Score in Patients with Liver Disease
por: Matsui, Masahiro, et al.
Publicado: (2023)

Prevalence of sarcopenia in pre-frail community dwelling older adult and utility of SARC-F, SARC-CalF and calf circumference in case finding
por: Lim, Jia Yi, et al.
Publicado: (2020)

Advances in the management of osteosarcoma
por: Bielack, Stefan S., et al.
Publicado: (2016)

Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia
por: Zasadzka, Ewa, et al.
Publicado: (2020)

Association of SARC-F Questionnaire and Mortality in Prevalent Hemodialysis Patients
por: Lin, Yu-Li, et al.
Publicado: (2020)

Identifying Patients with Osteoarthritis at Risk of Sarcopenia using the SARC-F
por: Lovett, Maggie, et al.
Publicado: (2021)

Prognostic Impact of the SARC-F Score in Gastrointestinal Advanced Cancers
por: Matsui, Masahiro, et al.
Publicado: (2021)

Sarcopenic Obesity in Individuals With Neurodisabilities: The SarcObeNDS Study
por: Dionyssiotis, Yannis, et al.
Publicado: (2022)

Use of the SARC-F Score as an Aid in Fragility Fractures Prevention
por: Martini, Carlos Augusto Nunes, et al.
Publicado: (2022)

Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients
por: Buddingh, Emilie P., et al.
Publicado: (2012)

Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics
por: Engert, Florian, et al.
Publicado: (2016)

Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients
por: Hecker-Nolting, Stefanie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_73o8qq397551t0m5hfe2rce503